Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Mar 22, 2023
Finance
March 22 Quick Takes: GordonMD, Pfizer Ventures lead Flare’s $123M B round
Plus: FDA approvals for Cidara, Incyte and updates from Karuna, Astellas, NImmune, AbbVie, Roche, Lilly
BioCentury | Dec 10, 2019
Finance
Perceptive launches $210M early-stage fund tied to Garabedian’s accelerator Xontogeny
Perceptive’s first early-stage fund will invest in fledgling companies progressing toward proof of concept
BioCentury | Apr 20, 2018
Emerging Company Profile
Clear for Landos
How Landos’ first-in-class LANCL2 agonist could improve upon existing IBD drugs
Items per page:
1 - 7 of 7